{"id":"W4409821988","doi":"10.1158/1538-7445.am2025-ct196","title":"Abstract CT196: Phase 1 dose escalation and expansion study of the PTK7-targeted antibody-drug conjugate DAY301 in patients with locally advanced or metastatic solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Antibody-drug conjugate; Medicine; Conjugate; Antibody; Drug; Solid tumor; Cancer research; Oncology; Cancer; Internal medicine; Monoclonal antibody; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007427768,0.00145031,0.00124769,0.0004627143,0.0003490825,0.0007685408,0.0009028247,0.00100153,0.005690567],"category_scores_gemma":[0.0005536816,0.000470673,0.0008873504,0.0004372342,0.0006356442,0.0005475354,0.0003373068,0.003067058,0.001594201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001252706,"about_ca_system_score_gemma":0.001639662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351047,"about_ca_topic_score_gemma":0.002968902,"domain_scores_codex":[0.9997616,0.00008505135,0.00001182276,0.00005255045,0.00003892093,0.00004994192],"domain_scores_gemma":[0.9996761,0.00003342073,0.00005664692,0.00003207001,0.00002866428,0.0001731273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4180584,0.1129483,0.008748217,0.001875148,0.001140862,0.0008455992,0.0005778061,0.008632995,0.2579653,0.0007540169,0.01767655,0.1707769],"study_design_scores_gemma":[0.3318091,0.6222383,0.01565301,0.00006817611,0.0003200173,0.0007917363,0.00007269029,0.002480846,0.01766114,0.0002547253,0.00860121,0.00004900445],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986573,0.001501506,0.00118071,0.0004100816,0.0001150597,0.004171005,0.002608883,0.0002595845,0.003180275],"genre_scores_gemma":[0.9787975,0.001504825,0.002901147,0.0008068013,0.00009713785,0.003694725,0.005577288,0.00007140793,0.006549168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005690567,"threshold_uncertainty_score":0.01903689,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03873785174044626,"score_gpt":0.4329273228387994,"score_spread":0.3941894710983531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}